While some remain concerned that the bill will reduce labs' leverage with payors, provisions like the use of arbitration for disputes are a win for providers.
Demand for SARS-CoV-2 testing sent lab revenues soaring while changes in patterns of patient care and regulations that could have impacts for years to come.
The COVID-19 pandemic is the highest priority for most, but laboratory organizations are also looking ahead with longer-term goals for the new presidency.
